Skip to content
Open access

Dynamic cellular programs of human cardiac allograft rejection revealed by spatial transcriptomics

Aug 2026 · Nature Cardiovascular Research · Vol 5, pp. 819 - 834 · 1 citation · 140 references
Medicine

TL;DR

Using spatial transcriptomics on longitudinal human cardiac biopsies, Amancherla, Oill and colleagues reveal marked cellular and molecular heterogeneity in transplanted hearts undergoing rejection, identify gene expression profiles linked to therapy response and outcomes, and show that acute rejection signatures are associated with chronic rejection development.

Abstract

Allograft rejection following solid-organ transplantation is a major cause of graft dysfunction and mortality. Current diagnostic approaches rely on histology, which exhibits wide diagnostic variability and lacks clinically relevant molecular phenotyping. Here we leverage image-based spatial transcriptomics at subcellular resolution in longitudinal human cardiac biopsies to characterize transcriptional heterogeneity in 62 adult and pediatric heart transplant recipients during and following histologically diagnosed rejection. Across 28 cell types, we identified significant differences in abundance in immune and parenchymal cells across different classes of rejection. We observed broad overlap in transcriptional states across rejection severity and significant heterogeneity within rejection grades. Responders and nonresponders to augmented therapies had distinct transcriptomic profiles, with nonresponders exhibiting baseline T cell hyperactivation and tissue remodeling genes. We also identified cell-specific genes linked to long-term outcomes after heart transplant. These results underscore the importance of subtyping cellular states during rejection to stratify immune–cardiac interactions relevant to short- and long-term outcomes. Using spatial transcriptomics on longitudinal human cardiac biopsies, Amancherla, Oill and colleagues reveal marked cellular and molecular heterogeneity in transplanted hearts undergoing rejection, identify gene expression profiles linked to therapy response and outcomes, and show that acute rejection signatures are associated with chronic rejection development.

Read PDF

Similar papers

Open access Sep 2026

Peripheral blood transcriptomes and a single-cell atlas suggest a monocyte-associated immune recovery-failure axis in STEMI

Background Patients with ST-segment elevation myocardial infarction (STEMI) continue to show substantial inflammatory heterogeneity after reperfusion therapy, and recovery trajectories may differ markedly across patients. Compared with traditional diagnostic models, characterizing the dynamic immune trajectory from acu...

Qin-Tian Cheng, Qun-Xing Li, De-Lu Yin · 0 citations
Open access Aug 2026

Longitudinal single-cell modeling reveals monocyte reprogramming in juvenile systemic sclerosis following autologous stem cell transplantation

Juvenile systemic sclerosis (jSSc) is a rare autoimmune disease marked by skin fibrosis and multi- organ involvement. Autologous stem cell transplantation (ASCT) is an emerging therapy for severe, treatment-refractory jSSc, but its effects on immune cell dynamics remain poorly understood. PBMCs were collected from thre...

Julia K. Elrod, Anwesha Sanyal, Theresa Hutchins et al. · 0 citations
Review Sep 2026

Spatial biology of liver transplantation: Mapping injury, immunity, and repair in the allograft.

The liver is a highly spatially organized organ in which microanatomy underpins metabolism, immune regulation, and regenerative capacity. In liver transplantation, spatially defined processes, including ischemia reperfusion injury (IRI), alloimmune activation, and disease recurrence critically shape graft function and...

Jason T. C. Lee, Heather Jennings, Diana Nakib et al. · 0 citations
Review Sep 2026

Macrophage heterogeneity in organ fibrosis in the era of single-cell omics

A theoretical basis is provided for understanding the pathogenesis of fibrosis and developing precision treatment strategies based on macrophage heterogeneity, as well as the therapeutic potential of targeting macrophage metabolic pathways, phenotypic transitions, and the elimination of specific subpopulations.

Wen-Hui Qiu, Ying Huang, Jia-Yi Chen et al. · 0 citations
Review Oct 2026

CLAD: translating basic science to clinical practice.

Chronic lung allograft dysfunction (CLAD), a fibrotic manifestation of chronic rejection, remains the major barrier to long-term survival after lung transplantation. CLAD is increasingly recognised as the final common pathway of diverse alloimmune injuries, augmented by non-alloimmune insults, that culminate in irrever...

A. Burman, Peter T. Bell, Daniel Chambers et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.